Trump’s travel restrictions will hurt cell therapy sector says ISCT – In-PharmaTechnologist.com

If reinstated, Donald Trumps order restricting travel to the US would hurt the cell therapy sector according to the International Society for Cellular Therapy (ISCT).

US President Donald Trump issued an executive order on January 27 that limited immigration from seven predominantly Muslim countries, halted refugee admission for 120 days, and barred all Syrian refugees.

Last Friday , a judge in Seattle suspended implementation of the order after lawyers representing Washington and Minnesota argued it was unconstitutional and discriminatory.

In response, Trump criticized the presiding judge and vowed to have the order reinstated. However, at the time of writing, nothing has been decided.

If reinstated, the travel restrictions will negatively impact the cell therapy sector according to the International Society for Cellular Therapy (ISCT) a Canada-based group representing doctors, regulators, researchers and industry which raised concerns in a statement today.

The US plays an essential part in cell therapy research as a leading country in the life science industry. It hosts the highest number of international conferences, critical for scientific collaboration and sharing of ideas.

The ISCT also highlighted the leading roles US investors and the FDA play in shaping the global cell therapy sector and warned against any regulations that restrict international collaboration.

ISCT views any policies that would prevent the free movement of properly credentialed scientists, patients, care givers and/or their families from entering the US, as significantly harmful to the sharing of key scientific findings and the ability to deliver cell therapy to all patients.

Read more from the original source:
Trump's travel restrictions will hurt cell therapy sector says ISCT - In-PharmaTechnologist.com